Ronghui Ju
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ronghui Ju has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Hongyi Li
Dalian Medical University, Dalian, Liaoning, China
2 shared publicationsMengyi Huang
Department of Radiology, The People’s Hospital of China Medical University, The People’s Hospital of Liaoning Province
2 shared publicationsQunbo Jia
Department of Radiology, The People’s Hospital of China Medical University, The People’s Hospital of Liaoning Province
2 shared publicationsXiaoteng Feng
Graduate School, Dalian Medical University
2 shared publicationsYushu Ouyang
Graduate School, Dalian Medical University
2 shared publicationsBai-Qing Chen
1 shared publication
Latest Publications
- Open Access
- 6 November 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 286
Radiomics analysis of brain–tumor interface on multiparametric MRI for prediction of brain metastasis primary site
Objectives: Brain metastasis (BM) frequently occurs in advanced cancer patients, and accurate identification of the primary origin is essential for personalized treatment. Conventional imaging often lacks sensitivity and specificity for BM source prediction. This study aimed to develop and validate a multiparametric MRI-based radiomics model emphasizing brain–tumor interface (BTI) features to improve noninvasive BM origin identification. Materials and methods: The primary cohort included 429 patients (740 BMs) from two centers, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), breast cancer (BC), and gastrointestinal cancer (GIC), and an independent validation cohort of 33 patients (84 BMs) from a third center. All underwent pre-treatment 3.0 T MRI with T1-weighted contrast-enhanced (T1CE) and T2-weighted (T2W) sequences. Radiomic features were extracted from tumor core and BTI regions (2, 4, 6, 8 mm). Least absolute shrinkage and selection operator (LASSO) regression was used for feature selection, and radiomics signatures (RS) were evaluated using receiver operating characteristic (ROC) analysis. Results: The constructed RS-BTI4 based on the 4-mm BTI region generated the best overall performance, with area under the ROC curve (AUCs) in the training cohort were 0.855 (LC/NLC), 0.910 (SCLC/NSCLC), and 0.890 (BC/GIC); in validation cohort, 0.726, 0.856, and 0.809; and in external validation cohort, 0.739, 0.750, and 0.792, respectively. RS-BTI4 consistently outperformed models based on other BTI radial widths and the whole tumor region in identifying the primary origin of BM. Conclusion: BTI-derived radiomic features demonstrate strong potential for noninvasive identification of BM origin, with the 4-mm BTI region showing optimal predictive performance. Key Points: Question Conventional MRI cannot reliably identify the primary origin of brain metastases, particularly when the primary tumor remains unknown at diagnosis. Findings The 4-mm brain–tumor interface model showed the most favorable overall performance, measured by area under the curve, across three binary classification tasks and validation cohorts. Critical relevance statement Integrating brain–tumor interface radiomics with multiparametric MRI may improve noninvasive estimation of BM origin and support more targeted diagnostic evaluation in clinical radiology.
- 6 November 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 286
Open AccessRadiomics analysis of brain–tumor interface on multiparametric MRI for prediction of brain metastasis primary site
Objectives: Brain metastasis (BM) frequently occurs in advanced cancer patients, and accurate identification of the primary origin is essential for personalized treatment. Conventional imaging often lacks sensitivity and specificity for BM source prediction. This study aimed to develop and validate a multiparametric MRI-based radiomics model emphasizing brain–tumor interface (BTI) features to improve noninvasive BM origin identification. Materials and methods: The primary cohort included 429 patients (740 BMs) from two centers, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), breast cancer (BC), and gastrointestinal cancer (GIC), and an independent validation cohort of 33 patients (84 BMs) from a third center. All underwent pre-treatment 3.0 T MRI with T1-weighted contrast-enhanced (T1CE) and T2-weighted (T2W) sequences. Radiomic features were extracted from tumor core and BTI regions (2, 4, 6, 8 mm). Least absolute shrinkage and selection operator (LASSO) regression was used for feature selection, and radiomics signatures (RS) were evaluated using receiver operating characteristic (ROC) analysis. Results: The constructed RS-BTI4 based on the 4-mm BTI region generated the best overall performance, with area under the ROC curve (AUCs) in the training cohort were 0.855 (LC/NLC), 0.910 (SCLC/NSCLC), and 0.890 (BC/GIC); in validation cohort, 0.726, 0.856, and 0.809; and in external validation cohort, 0.739, 0.750, and 0.792, respectively. RS-BTI4 consistently outperformed models based on other BTI radial widths and the whole tumor region in identifying the primary origin of BM. Conclusion: BTI-derived radiomic features demonstrate strong potential for noninvasive identification of BM origin, with the 4-mm BTI region showing optimal predictive performance. Key Points: Question Conventional MRI cannot reliably identify the primary origin of brain metastases, particularly when the primary tumor remains unknown at diagnosis. Findings The 4-mm brain–tumor interface model showed the most favorable overall performance, measured by area under the curve, across three binary classification tasks and validation cohorts. Critical relevance statement Integrating brain–tumor interface radiomics with multiparametric MRI may improve noninvasive estimation of BM origin and support more targeted diagnostic evaluation in clinical radiology.
- Open Access
- 4 May 2026
- Published by Frontiers Media SA in Frontiers in Neuroimaging
- Vol. 5, 1691870
Imaging research, diagnosis, and treatment advances of post-stroke cognitive impairment
Post-stroke cognitive impairment (PSCI) has garnered widespread attention due to its high incidence and its association with increased risk of stroke recurrence and mortality. Growing evidence indicates that early prediction of PSCI and the implementation of effective interventions can help delay disease progression and improve long-term patient outcomes. With advances in imaging technology, the role of neuroimaging has evolved from traditional anatomical localization to a multimodal assessment system that integrates macrostructural, microstructural connectivity, and molecular metabolic information. Imaging features can serve as objective and reproducible quantitative indicators, sensitively capturing subtle pathological changes in brain tissue, thereby providing a reliable basis for clinical diagnosis, treatment strategy formulation, and prevention. This review systematically summarizes recent research progress in the clinical diagnosis and imaging characteristics of PSCI. It focuses on analyzing the impact and underlying mechanisms of specific biomarkers, gene expression, cerebral small vessel disease, and cerebral perfusion abnormalities on cognitive function, and further explores the application prospects of advanced imaging technologies in the assessment of PSCI.
- 4 May 2026
- Published by Frontiers Media SA in Frontiers in Neuroimaging
- Vol. 5, 1691870
Open AccessImaging research, diagnosis, and treatment advances of post-stroke cognitive impairment
Post-stroke cognitive impairment (PSCI) has garnered widespread attention due to its high incidence and its association with increased risk of stroke recurrence and mortality. Growing evidence indicates that early prediction of PSCI and the implementation of effective interventions can help delay disease progression and improve long-term patient outcomes. With advances in imaging technology, the role of neuroimaging has evolved from traditional anatomical localization to a multimodal assessment system that integrates macrostructural, microstructural connectivity, and molecular metabolic information. Imaging features can serve as objective and reproducible quantitative indicators, sensitively capturing subtle pathological changes in brain tissue, thereby providing a reliable basis for clinical diagnosis, treatment strategy formulation, and prevention. This review systematically summarizes recent research progress in the clinical diagnosis and imaging characteristics of PSCI. It focuses on analyzing the impact and underlying mechanisms of specific biomarkers, gene expression, cerebral small vessel disease, and cerebral perfusion abnormalities on cognitive function, and further explores the application prospects of advanced imaging technologies in the assessment of PSCI.
- Open Access
- 31 March 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Autoimmune glial fibrillary acidic protein astrocytopathy with full-length spinal cord lesions: a case report and literature review
Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is an autoimmune inflammatory disease of the central nervous system triggered by GFAP. C
- 31 March 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessAutoimmune glial fibrillary acidic protein astrocytopathy with full-length spinal cord lesions: a case report and literature review
Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is an autoimmune inflammatory disease of the central nervous system triggered by GFAP. C
- 21 October 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (10) , 2064-2072
Incremental value of pericarotid adipose tissue radiomics in predicting in-stent restenosis after carotid artery stenting
Objective To evaluate the potential of pericarotid adipose tissue radiomics to improve the prediction of in-stent restenosis (ISR) after carotid artery stenting (CAS). Methods This retrospective study included 191 patients who underwent carotid CT angiography (CTA) and CAS within 1 week at two centers from September 2019 to December 2023. ISR was defined as ≥50% stenosis on follow-up Doppler ultrasound or CTA. Three predictive models were developed and defined as follows: Model A (Clinical), Model B (Clinical + Imaging), and Model C (Clinical + Imaging + Radiomics) using receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis. Results ISR occurred in 44 patients with a mean time interval of 11.3 months. Multivariate Cox regression analyses identified diabetes, fibrinogen, systolic blood pressure, calcified plaque volume, and pericarotid adipose tissue radiomics as independent predictors of ISR. The radiomics score, derived from 15 significant characteristics, outperformed conventional imaging markers. In the training set, Model C (AUC=0.881) significantly outperformed Model A (AUC=0.664) and Model B (AUC=0.840), with statistically significant differences (Model A vs Model C: P=0.001; Model B vs Model C: P=0.0246). This trend was consistent in the validation sets. Calibration curves showed good agreement between predicted and actual ISR probabilities, and decision curve analysis indicated that Model C provided greater net benefits. Conclusion The radiomic characteristics of pericarotid adipose tissue provide incremental value in predicting ISR after CAS and serve as a valuable biomarker for restenosis risk assessment.
- 21 October 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (10) , 2064-2072
Incremental value of pericarotid adipose tissue radiomics in predicting in-stent restenosis after carotid artery stenting
Objective To evaluate the potential of pericarotid adipose tissue radiomics to improve the prediction of in-stent restenosis (ISR) after carotid artery stenting (CAS). Methods This retrospective study included 191 patients who underwent carotid CT angiography (CTA) and CAS within 1 week at two centers from September 2019 to December 2023. ISR was defined as ≥50% stenosis on follow-up Doppler ultrasound or CTA. Three predictive models were developed and defined as follows: Model A (Clinical), Model B (Clinical + Imaging), and Model C (Clinical + Imaging + Radiomics) using receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis. Results ISR occurred in 44 patients with a mean time interval of 11.3 months. Multivariate Cox regression analyses identified diabetes, fibrinogen, systolic blood pressure, calcified plaque volume, and pericarotid adipose tissue radiomics as independent predictors of ISR. The radiomics score, derived from 15 significant characteristics, outperformed conventional imaging markers. In the training set, Model C (AUC=0.881) significantly outperformed Model A (AUC=0.664) and Model B (AUC=0.840), with statistically significant differences (Model A vs Model C: P=0.001; Model B vs Model C: P=0.0246). This trend was consistent in the validation sets. Calibration curves showed good agreement between predicted and actual ISR probabilities, and decision curve analysis indicated that Model C provided greater net benefits. Conclusion The radiomic characteristics of pericarotid adipose tissue provide incremental value in predicting ISR after CAS and serve as a valuable biomarker for restenosis risk assessment.
- Open Access
Radiomics machine learning based on asymmetrically prominent cortical and deep medullary veins combined with clinical features to predict prognosis in acute ischemic stroke: a retrospective study
Background: Acute ischemic stroke (AIS) has a poor prognosis and a high recurrence rate. Predicting the outcomes of AIS patients in the early stages of the disease is therefore important. The establishment of intracerebral collateral circulation significantly improves the survival of brain cells and the outcomes of AIS patients. However, no machine learning method has been applied to investigate the correlation between the dynamic evolution of intracerebral venous collateral circulation and AIS prognosis. Therefore, we employed a support vector machine (SVM) algorithm to analyze asymmetrically prominent cortical veins (APCVs) and deep medullary veins (DMVs) to establish a radiomic model for predicting the prognosis of AIS by combining clinical indicators. Methods: The magnetic resonance imaging (MRI) data and clinical indicators of 150 AIS patients were retrospectively analyzed. Regions of interest corresponding to the DMVs and APCVs were delineated, and least absolute shrinkage and selection operator (LASSO) regression was used to select features extracted from these regions. An APCV-DMV radiomic model was created via the SVM algorithm, and independent clinical risk factors associated with AIS were combined with the radiomic model to generate a joint model. The SVM algorithm was selected because of its proven efficacy in handling high-dimensional radiomic data compared with alternative classifiers (e.g., random forest) in pilot experiments. Results: Nine radiomic features associated with AIS patient outcomes were ultimately selected. In the internal training test set, the AUCs of the clinical, DMV–APCV radiomic and joint models were 0.816, 0.976 and 0.996, respectively. The DeLong test revealed that the predictive performance of the joint model was better than that of the individual models, with a test set AUC of 0.996, sensitivity of 0.905, and specificity of 1.000 (P < 0.05). Conclusions: Using radiomic methods, we propose a novel joint predictive model that combines the imaging histologic features of the APCV and DMV with clinical indicators. This model quantitatively characterizes the morphological and functional attributes of venous collateral circulation, elucidating its important role in accurately evaluating the prognosis of patients with AIS and providing a noninvasive and highly accurate imaging tool for early prognostic prediction.
Open AccessRadiomics machine learning based on asymmetrically prominent cortical and deep medullary veins combined with clinical features to predict prognosis in acute ischemic stroke: a retrospective study
Background: Acute ischemic stroke (AIS) has a poor prognosis and a high recurrence rate. Predicting the outcomes of AIS patients in the early stages of the disease is therefore important. The establishment of intracerebral collateral circulation significantly improves the survival of brain cells and the outcomes of AIS patients. However, no machine learning method has been applied to investigate the correlation between the dynamic evolution of intracerebral venous collateral circulation and AIS prognosis. Therefore, we employed a support vector machine (SVM) algorithm to analyze asymmetrically prominent cortical veins (APCVs) and deep medullary veins (DMVs) to establish a radiomic model for predicting the prognosis of AIS by combining clinical indicators. Methods: The magnetic resonance imaging (MRI) data and clinical indicators of 150 AIS patients were retrospectively analyzed. Regions of interest corresponding to the DMVs and APCVs were delineated, and least absolute shrinkage and selection operator (LASSO) regression was used to select features extracted from these regions. An APCV-DMV radiomic model was created via the SVM algorithm, and independent clinical risk factors associated with AIS were combined with the radiomic model to generate a joint model. The SVM algorithm was selected because of its proven efficacy in handling high-dimensional radiomic data compared with alternative classifiers (e.g., random forest) in pilot experiments. Results: Nine radiomic features associated with AIS patient outcomes were ultimately selected. In the internal training test set, the AUCs of the clinical, DMV–APCV radiomic and joint models were 0.816, 0.976 and 0.996, respectively. The DeLong test revealed that the predictive performance of the joint model was better than that of the individual models, with a test set AUC of 0.996, sensitivity of 0.905, and specificity of 1.000 (P < 0.05). Conclusions: Using radiomic methods, we propose a novel joint predictive model that combines the imaging histologic features of the APCV and DMV with clinical indicators. This model quantitatively characterizes the morphological and functional attributes of venous collateral circulation, elucidating its important role in accurately evaluating the prognosis of patients with AIS and providing a noninvasive and highly accurate imaging tool for early prognostic prediction.
- Open Access
- 25 October 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 1629570
Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta‐Analysis
To analyse the value of the apparent diffusion coefficient (ADC) in diffusion‐weighted imaging (DWI) and the choline (Cho)/creatine (Cr) ratio and Cho/N‐acetyl‐aspartate (NAA) ratio in magnetic resonance spectroscopy (MRS) in the differential diagnosis between recurrent glioma and radiation injury. Chinese and English studies related to the diagnosis of recurrent glioma and radiation injury using DWI and MRS and published before 15 October 2022 were retrieved from PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure, China Biomedical Literature Database, VIP Journal Database, and Wanfang Database for a meta‐analysis. A total of 11 articles were included in this study. ADC was lower in the recurrent glioma group than in the radiation injury group (standardized mean difference = −1.29, 95% confidence interval (CI) (−1.87, −0.71), P < 0.001). The Cho/Cr ratio was higher in the recurrent glioma group than in the radiation injury group (weighted mean difference = 0.65, 95% CI (0.40, 0.90), and P < 0.001). The Cho/NAA ratio was higher in the recurrent glioma group than in the radiation injury group, as evidenced by the sensitivity analysis. The sensitivity and specificity of the Cho/Cr ratio were 0.85 (0.73–0.92) and 0.82 (0.67–0.91), respectively, and the area under the curve was 0.86. The sensitivity and specificity of the Cho/NAA ratio were 0.82 (0.66–0.91) and 0.94 (0.69–0.99), respectively, and the area under the curve was 0.93. This meta‐analysis showed that ADC, Cho/Cr, and Cho/NAA ratios all had high sensitivity and specificity. Therefore, DWI combined with MRS can effectively improve the diagnosis of recurrent glioma and radiation injury.
- 25 October 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 1629570
Open AccessValue of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta‐Analysis
To analyse the value of the apparent diffusion coefficient (ADC) in diffusion‐weighted imaging (DWI) and the choline (Cho)/creatine (Cr) ratio and Cho/N‐acetyl‐aspartate (NAA) ratio in magnetic resonance spectroscopy (MRS) in the differential diagnosis between recurrent glioma and radiation injury. Chinese and English studies related to the diagnosis of recurrent glioma and radiation injury using DWI and MRS and published before 15 October 2022 were retrieved from PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure, China Biomedical Literature Database, VIP Journal Database, and Wanfang Database for a meta‐analysis. A total of 11 articles were included in this study. ADC was lower in the recurrent glioma group than in the radiation injury group (standardized mean difference = −1.29, 95% confidence interval (CI) (−1.87, −0.71), P < 0.001). The Cho/Cr ratio was higher in the recurrent glioma group than in the radiation injury group (weighted mean difference = 0.65, 95% CI (0.40, 0.90), and P < 0.001). The Cho/NAA ratio was higher in the recurrent glioma group than in the radiation injury group, as evidenced by the sensitivity analysis. The sensitivity and specificity of the Cho/Cr ratio were 0.85 (0.73–0.92) and 0.82 (0.67–0.91), respectively, and the area under the curve was 0.86. The sensitivity and specificity of the Cho/NAA ratio were 0.82 (0.66–0.91) and 0.94 (0.69–0.99), respectively, and the area under the curve was 0.93. This meta‐analysis showed that ADC, Cho/Cr, and Cho/NAA ratios all had high sensitivity and specificity. Therefore, DWI combined with MRS can effectively improve the diagnosis of recurrent glioma and radiation injury.